Ocugen (OCGN) Total Liabilities (2014 - 2026)
Ocugen posted quarterly Total Liabilities of $51.1 million for Q1 2026, up 5.26% year-on-year from $48.5 million in Q1 2025, and down 8.23% on a QoQ basis from $55.7 million in Q4 2025.
Ocugen (OCGN) has 13 years of Total Liabilities data on file, last reported at $51.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 5.26% year-over-year to $51.1 million; the trailing twelve-month figure through Mar 2026 stood at $51.1 million (up 5.26% YoY), and the FY2025 full-year result was $55.7 million, up 5.44% from the prior year.
- Total Liabilities for Q1 2026 stood at $51.1 million, down from $55.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $55.7 million in Q4 2025 and bottomed at $16.2 million in Q1 2022.
- The 5-year median for Total Liabilities is $30.6 million (2022), against an average of $35.0 million.
- The widest annual swing landed in 2022, when Total Liabilities jumped 248.5%; it then tumbled 31.42% in 2024.
- A 5-year view of Total Liabilities shows it stood at $34.7 million in 2022, then sank by 30.79% to $24.0 million in 2023, then soared by 120.2% to $52.8 million in 2024, then advanced by 5.44% to $55.7 million in 2025, then fell by 8.23% to $51.1 million in 2026.
- The last three Total Liabilities figures came in at $51.1 million (Q1 2026), $55.7 million (Q4 2025), and $54.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | 51.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.10 Mn |
| Dec 31, 2025 | 55.68 Mn |
| Sep 30, 2025 | 54.06 Mn |
| Jun 30, 2025 | 50.54 Mn |
| Mar 31, 2025 | 48.55 Mn |
| Dec 31, 2024 | 52.81 Mn |
| Sep 30, 2024 | 21.31 Mn |
| Jun 30, 2024 | 23.62 Mn |
| Mar 31, 2024 | 21.53 Mn |
| Dec 31, 2023 | 23.98 Mn |
| Sep 30, 2023 | 24.89 Mn |
| Jun 30, 2023 | 29.73 Mn |
| Mar 31, 2023 | 31.40 Mn |
| Dec 31, 2022 | 34.65 Mn |
| Sep 30, 2022 | 30.55 Mn |
| Jun 30, 2022 | 23.61 Mn |
| Mar 31, 2022 | 16.21 Mn |
| Dec 31, 2021 | 9.94 Mn |
| Sep 30, 2021 | 9.20 Mn |
| Jun 30, 2021 | 7.84 Mn |
| Mar 31, 2021 | 7.36 Mn |
| Dec 31, 2020 | 5.83 Mn |
| Sep 30, 2020 | 6.12 Mn |
| Jun 30, 2020 | 9.14 Mn |
| Mar 31, 2020 | 5.02 Mn |
| Dec 31, 2019 | 5.79 Mn |
| Sep 30, 2019 | 36.71 Mn |
| Jun 30, 2019 | 11.93 Mn |
| Mar 31, 2019 | 20.37 Mn |
| Dec 31, 2018 | 15.16 Mn |
| Sep 30, 2018 | 20.56 Mn |
| Jun 30, 2018 | 38.59 Mn |
| Mar 31, 2018 | 41.40 Mn |
| Dec 31, 2017 | 22.30 Mn |
| Sep 30, 2017 | 20.64 Mn |
| Jun 30, 2017 | 21.32 Mn |
| Mar 31, 2017 | 21.34 Mn |
| Dec 31, 2016 | 22.51 Mn |
| Sep 30, 2016 | 38.76 Mn |
| Jun 30, 2016 | 8.39 Mn |
| Mar 31, 2016 | 7.92 Mn |
| Dec 31, 2015 | 8.59 Mn |
| Sep 30, 2015 | 9.13 Mn |
| Jun 30, 2015 | 9.37 Mn |
| Mar 31, 2015 | 10.36 Mn |
| Dec 31, 2014 | 11.29 Mn |